These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


304 related items for PubMed ID: 15093911

  • 1. Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma.
    Thurman SA, Schnitt SJ, Connolly JL, Gelman R, Silver B, Harris JR, Recht A.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):152-9. PubMed ID: 15093911
    [Abstract] [Full Text] [Related]

  • 2. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
    Di Saverio S, Gutierrez J, Avisar E.
    Breast Cancer Res Treat; 2008 Oct 01; 111(3):541-7. PubMed ID: 18026874
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods.
    Skowronek J, Piotrowski T.
    Neoplasma; 2002 Oct 01; 49(6):426-31. PubMed ID: 12584593
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China.
    Cao AY, He M, Liu ZB, Di GH, Wu J, Lu JS, Liu GY, Shen ZZ, Shao ZM.
    Ann Surg Oncol; 2012 Sep 01; 19(9):3019-27. PubMed ID: 22451233
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinicopathologic features and long-term outcome of patients with medullary breast carcinoma managed with breast-conserving therapy (BCT).
    Vu-Nishino H, Tavassoli FA, Ahrens WA, Haffty BG.
    Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):1040-7. PubMed ID: 15990007
    [Abstract] [Full Text] [Related]

  • 11. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ, Huh SJ, Yang JH, Park W, Nam SJ, Kim JH, Lee JH, Kang SS, Lee JE, Kang MK, Park YJ, Nam HR.
    Jpn J Clin Oncol; 2005 Mar 15; 35(3):126-33. PubMed ID: 15741302
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
    Pass H, Vicini FA, Kestin LL, Goldstein NS, Decker D, Pettinga J, Ingold J, Benitez P, Neumann K, Rebner M, Dekhne N, Martinez A.
    Cancer; 2004 Aug 15; 101(4):713-20. PubMed ID: 15305400
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tubular carcinoma of the breast: outcome and loco-regional recurrence in 307 patients.
    Livi L, Paiar F, Meldolesi E, Talamonti C, Simontacchi G, Detti B, Salerno S, Bianchi S, Cardona G, Biti GP.
    Eur J Surg Oncol; 2005 Feb 15; 31(1):9-12. PubMed ID: 15642419
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma.
    Vo TN, Meric-Bernstam F, Yi M, Buchholz TA, Ames FC, Kuerer HM, Bedrosian I, Hunt KK.
    Am J Surg; 2006 Oct 15; 192(4):552-5. PubMed ID: 16978974
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.